Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report

Dermatomyositis (DM) positive for anti-melanoma differentiation-associated gene 5 (MDA5) antibodies, mainly when linked with rapidly progressive interstitial lung disease (RP-ILD), is considered a refractory disease. Our report describes a critical case of clinically amyopathic dermatomyositis (CADM...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Gui-Chen Ling, Chang Su, Ying-Ao Guo, Xia Qiu, Jia-Wei Liu, Min Xiao, Yu-Ya Xiao, Shuo Yang, Jian-Yong Zhang, Jing-Jing Xie
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-10-01
Edice:	Frontiers in Pharmacology
Témata:	anti-MDA5-associated dermatomyositis case report rapidly progressive interstitial lung disease mycophenolate mofetil clinically amyopathic dermatomyositis (CADM)
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1472667/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!